Evaluating Diagnostic Strategies Involving Multiple Tests

Published May 17, 2013
Leicester, UK – It is essential that the relationships between diagnostic tests are understood in order to ensure the most effective diagnoses of diseases, as they rarely perform independently. To date, both clinical and economic evaluations of combinations of diagnostic tests have mostly assumed the tests to perform independently of one another. However, doing so will often over-estimate the performance of sequences of diagnostic tests. Researchers from the University of Leicester attempted to show how failure to allow for correlations between test performance may led to erroneous conclusions. By creating a framework for the evaluation of the diagnostic performance of sequences of tests and applying the framework to an economic evaluation of diagnostic strategies for Deep Vein Thrombosis, they determined that allowing for correlations between tests had considerable impact on the evaluation results. Professor Alex Sutton, researcher on the studies says, "As well as presenting a novel method in an under-researched area, this work also has important implications for those designing diagnostic evaluation studies in the future since it highlights the need for studies which evaluate multiple tests." The full studies: “Evaluating the Cost-Effectiveness of Diagnostic Tests in Combination: Is It Important to Allow for Performance Dependency?” and “Meta-Analysis of the Accuracy of Two Diagnostic Tests Used in Combination: Application to the Ddimer Test and the Wells Score for the Diagnosis of Deep Vein Thrombosis” are published in Value in Health.

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

For more information: www.ispor.org

Related Stories

Global Expert Panel Releases Good Practices Guidance for Developing or Updating Health Technology Assessment Guidelines

Jan 14, 2025

ISPOR announced today the publication of a tripartite task force report outlining good practices for developing or updating health technology assessment (HTA) guidelines.

Rethinking Value Assessment for Orphan Drugs

Dec 18, 2024

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of a special themed section of research papers that document challenges in rare disease evidence and economic evaluation and policy as well as ways in which the environment is evolving to address them.

ISPOR Releases Emerging Good Practices Guidance on Quantifying Specialized Knowledge in Healthcare

Nov 6, 2024

ISPOR announced the publication of an ISPOR Good Practices Report that identifies existing structured expert elicitation protocols that can support healthcare decision making and provides important insights on how to choose which protocols may be the most appropriate for different scenarios, such as time-constrained decisions, early-stage technology assessments, and public health policies.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×